Cancer & Infectious disease vaccines, contract services
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
39
NCT07088822
A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 15, 2025
Completion: Dec 31, 2026
Loading map...